Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAIVE Trial: Ivermectin for Prevention of COVID-19
2021-001938-19Phase 2Completed
- Sponsor
- MedinCell
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Ivermectin arm with Placebo arm (2 arms). Primary endpoint: Proportion of laboratory-confirmed COVID-19 infections between baseline and Day 28. Started Feb 2022; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2021-001938-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001938-19.